Cited by 1,007Schizophrenia research and treatmentPsychometric Methodologies and TestingPsychological Testing and Assessment

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Reliability and validity of the positive and negative syndrome scale for schizophrenics

Kay, Stanley R., Opler, Lewis A., Lindenmayer, Jean-Pierre·1988·Psychiatry Research

DOI 10.1016/0165-1781(88)90038-8

Open this paper in CoChat — free account

Abstract

The Positive and Negative Syndrome Scale (PANSS) was developed out of the need for a well-operationalized method of assessing these syndromes in schizophrenia, including their relationship to one another and to global psychopathology. We surveyed 82 acute and chronic schizophrenics to analyze the psychometric properties of the four PANSS scales. The interrater reliabilities were in the 0.80's, and significant correlations emerged with corresponding criterion measures. The PANSS positive and negative scales were inversely intercorrelated once their shared association with general psychopathology had been partialed out. The results support the scales' reliability, criterion-related validity, and construct validity, while cross-validating some of our previous findings.

Integrity signals

Registry

Crossref · 10.1016/0165-1781(88)90038-8

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378
The Brief Psychiatric Rating Scale.
Overall, J. E., & Gorham, D. R. (1962) · Psychological Reports · doi:10.2466/pr0.1962.10.3.799 · Cited by 11,090
Untitled work
(1976) · Medical Entomology and Zoology · Cited by 8,899
Negative Symptoms in Schizophrenia: Definition and Reliability
Andreasen, N. C. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290070020005 · Cited by 2,247
Negative v Positive Schizophrenia
Andreasen, N. C. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290070025006 · Cited by 2,008
Positive and Negative Schizophrenic Symptoms and the Role of Dopamine
Crow, T. J. (1980) · The British Journal of Psychiatry · doi:10.1192/s0007125000071919 · Cited by 563
Treatment of Negative Symptoms
Carpenter, W. T., Heinrichs, D. W., & Alphs, L. D. (1985) · Schizophrenia Bulletin · doi:10.1093/schbul/11.3.440 · Cited by 508
Symptomatic and Neuropsychological Components of Defect States
Bilder, R. M., Mukherjee, S., Rieder, R. O., & Pandurangi, A. K. (1985) · Schizophrenia Bulletin · doi:10.1093/schbul/11.3.409 · Cited by 504
Differential effects of amphetamine and neuroleptics on negative vs. positive symptoms in schizophrenia
Angrist, B., Rotrosen, J., & Gershon, S. (1980) · Psychopharmacology · doi:10.1007/bf00433802 · Cited by 344
Positive and negative symptoms in schizophrenia
Rosen, W. G., Mohs, R. C., Johns, C. A., Small, N. S., Kendler, K. S., Horvath, T., & Davis, K. L. (1984) · Psychiatry Research · doi:10.1016/0165-1781(84)90075-1 · Cited by 238

Show all 28 references

Research works printed but not linked: 1

Kay, 1981, Arousal in schizophrenia: Toward a dual-process model and framework for research, JSAS Catalog of Selected Documents in Psychology, 11, 35

Sorted by citations

Items 101–200 of 998

One-year randomized trial comparing virtual reality-assisted therapy to cognitive–behavioral therapy for patients with treatment-resistant schizophrenia
Dellazizzo, L., Potvin, S., Phraxayavong, K., & Dumais, A. (2021) · Schizophrenia · doi:10.1038/s41537-021-00139-2 · Cited by 100
Linguistic Markers Indicating Therapeutic Outcomes of Social Media Disclosures of Schizophrenia
Ernala, S. K., Rizvi, A. F., Birnbaum, M. L., Kane, J. M., & De Choudhury, M. (2017) · Proceedings of the ACM on Human-Computer Interaction · doi:10.1145/3134678 · Cited by 99
Olfactory deficits, cognition and negative symptoms in early onset psychosis
Corcoran, C. M., Whitaker, A. H., Coleman, E. A., Fried, J., Feldman, J., Goudsmit, N., & Malaspina, D. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.07.028 · Cited by 99
Schneiderian symptoms and childhood trauma in the general population
Ross, C. A., & Joshi, S. (1992) · Comprehensive Psychiatry · doi:10.1016/0010-440x(92)90052-r · Cited by 97
Pharmacogenetics of Response to Antipsychotics in Patients with Schizophrenia
Arranz, M. J., Rivera, M., & Munro, J. C. (2011) · CNS Drugs · doi:10.2165/11595380-000000000-00000 · Cited by 97
Large-scale evaluation of the Positive and Negative Syndrome Scale (PANSS) symptom architecture in schizophrenia
Lim, K., Peh, O. H., Yang, Z., Rekhi, G., Rapisarda, A., See, Y. M., Rashid, N. A. A., Ang, M. S., Lee, S.-A., Sim, K., et al. (2021) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2021.102732 · Cited by 99
Working memory correlates of three symptom clusters in schizophrenia
Cameron, A. M., Oram, J., Geffen, G. M., Kavanagh, D. J., McGrath, J. J., & Geffen, L. B. (2002) · Psychiatry Research · doi:10.1016/s0165-1781(02)00036-7 · Cited by 96
In Vivo Extrastriatal and Striatal D2 Dopamine Receptor Blockade by Amisulpride in Schizophrenia
Xiberas, X., Martinot, J., Mallet, L., Eric Artiges, A., Canal, M., Loc’h, C., Maziere, B., & Martinot, M. P. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200104000-00013 · Cited by 95
Differential effects of the D1-DA receptor antagonist SCH39166 on positive and negative symptoms of schizophrenia
den Boer, J. A., van Megen, H. J. G. M., Slaap, B. R., Westenberg, H. G. M., Fleischhacker, W. W., Louwerens, J. W., Burrows, G. D., & Srivastava, O. N. (1995) · Psychopharmacology · doi:10.1007/bf02246069 · Cited by 95
Placebo-Controlled Study of the D4/5-HT2A Antagonist Fananserin in the Treatment of Schizophrenia
Truffinet, P., Tamminga, C. A., Fabre, L. F., Meltzer, H. Y., re, M.-E. R. ⁄., & Papillon-Downey, C. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.3.419 · Cited by 94
Positive symptoms and white matter microstructure in never-medicated first episode schizophrenia
Cheung, V., Chiu, C. P. Y., Law, C. W., Cheung, C. C. G., Hui, C. L. M., Chan, K. K. S., Sham, P. C., Deng, M., Tai, K. S., Khong, P., et al. (2010) · Psychological Medicine · doi:10.1017/s003329171000156x · Cited by 92
A forced five-dimensional factor analysis and concurrent validity of the Positive and Negative Syndrome Scale in Mexican schizophrenic patients
Fresán, A., de la Fuente‐Sandoval, C., Lóyzaga, C., García‐Anaya, M., Meyenberg, N., Nicolini, H., & Apiquián, R. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.03.021 · Cited by 92
Quantitative EEG in schizophrenia and in response to acute and chronic clozapine treatment
Knott, V., Labelle, A., Jones, B., & Mahoney, C. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(00)00165-1 · Cited by 92
Neural Correlates of Emotion Regulation in Patients with Schizophrenia and Non-Affected Siblings
van der Meer, L., Swart, M., van der Velde, J., Pijnenborg, G. H. M., Wiersma, D., Bruggeman, R., & Aleman, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099667 · Cited by 91
Reliability and validity of the Chinese versions of the Scales for Assessment of Positive and Negative Symptoms
Phillips, M. R., Xiong, W., Wang, R. W., Gao, Y. H., Wang, X. Q., & Zhang, N. P. (1991) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1991.tb03161.x · Cited by 90
Attentional deficits in patients with schizophrenia and in their non-psychotic first-degree relatives
Laurent, A., Saoud, M., Bougerol, T., d’Amato, T., Anchisi, A.-M., Biloa-Tang, M., Jean Dalery, A., & Rochet, T. (1999) · Psychiatry Research · doi:10.1016/s0165-1781(99)00109-2 · Cited by 89
Relationships between worry, psychotic experiences and emotional distress in patients with schizophrenia spectrum diagnoses and comparisons with anxious and non-patient groups.
Morrison, A., & Wells, A. (2007) · Behaviour Research and Therapy · doi:10.1016/j.brat.2006.11.010 · Cited by 90
Working memory in schizophrenia and mania: correlation with symptoms during the acute and subacute phases
McGrath, J. J., Chapple, B., & Wright, M. J. (2001) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2001.00114.x · Cited by 87
Serum lipid profiles and schizophrenia: Effects of conventional or atypical antipsychotic drugs in Taiwan
Huang, T., & Chen, J. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.05.001 · Cited by 87
Psychometric evaluation of the Medication Satisfaction Questionnaire (MSQ) to assess satisfaction with antipsychotic medication among schizophrenia patients
Vernon, M., Revicki, D. A., Awad, A. G., Dirani, R. D., Panish, J. M., Canuso, C. M., Grinspan, A., Mannix, S., & Kalali, A. H. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.01.021 · Cited by 87
Assessment of psychiatric symptoms using the SCL-90
Holi, M. M. (2003) · Työväentutkimus Vuosikirja · Cited by 87
Patterns of neurocognitive impairment in first-episode bipolar disorder and schizophrenia
Barrett, S., Mulholland, C. C., Cooper, S. J., & Rushe, T. (2009) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.108.054874 · Cited by 86
ZNF804A risk allele is associated with relatively intact gray matter volume in patients with schizophrenia
Donohoe, G. J., Rose, E. J., Frodl, T., Morris, D. W., Spoletini, I., Adriano, F., Bernardini, S., Caltagirone, C., Bossù, P., Gill, M., et al. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.09.089 · Cited by 87
Absence of evidence for bornavirus infection in schizophrenia, bipolar disorder and major depressive disorder
Hornig, M., Briese, T., Licinio, J., KHABBAZ, R. F., Altshuler, L. L., Potkin, S. G., Schwemmle, M., Siemetzki, U., Mintz, J., Honkavuori, K. S., et al. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.179 · Cited by 85
Cognitive Performance of Individuals With Schizophrenia Across Seven Decades: A Study Using the MATRICS Consensus Cognitive Battery
Rajji, T. K., Voineskos, A. N., Butters, M. A., Miranda, D., Arenovich, T., Menon, M., Ismail, Z., Kern, R. S., & Mulsant, B. H. (2013) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2012.10.011 · Cited by 88
Neurological soft signs discriminate schizophrenia from major depression but not bipolar disorder
Zhao, Q., Ma, Y., Lui, S. S. Y., Liu, W., Xu, T., Yu, X., Tan, S., Wang, Z., Qu, M., Wang, Y., et al. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.12.006 · Cited by 85
Remission and cognitive ability in a cohort of patients with schizophrenia
Helldin, L., Kane, J. M., Karilampi, U., Norlander, T., & Archer, T. (2006) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.07.005 · Cited by 84
The structure of schizophrenic symptoms: a meta-analytic confirmatory factor analysis
Smith, D. A., Mar, C. M., & Turoff, B. K. (1998) · Schizophrenia Research · doi:10.1016/s0920-9964(98)00009-7 · Cited by 84
Transcranial magnetic stimulation of Wernicke's and right homologous sites to curtail “voices”: a randomized trial
Hoffman, R. E., Wu, K., Pittman, B., Cahill, J. D., Hawkins, K. A., Fernandez, T., & Hannestad, J. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.01.016 · Cited by 82
The metacognitive beliefs account of hallucinatory experiences: A literature review and meta-analysis
Varese, F., & Bentall, R. P. (2010) · Clinical Psychology Review · doi:10.1016/j.cpr.2010.12.001 · Cited by 88
Metacognitive therapy in people with a schizophrenia spectrum diagnosis and medication resistant symptoms: A feasibility study
Morrison, A. P., Pyle, M., Chapman, N., French, P., Parker, S. K., & Wells, A. (2014) · Journal of Behavior Therapy and Experimental Psychiatry · doi:10.1016/j.jbtep.2013.11.003 · Cited by 82
Neurocognitive deficits and neurological signs in schizophrenia
Wong, A. H. C., Voruganti, L. N. P., Heslegrave, R. J., & Awad, A. G. (1997) · Schizophrenia Research · doi:10.1016/s0920-9964(96)00095-3 · Cited by 82
Negative Symptomatology and Schizophrenia: A Conceptual and Empirical Review
Pogue‐Geile, M. F., & Zubin, J. (1987) · International Journal of Mental Health · doi:10.1080/00207411.1987.11449074 · Cited by 82
Neurobiological effects of physical exercise in schizophrenia: a systematic review.
Vancampfort, D., Probst, M., De Hert, M., Soundy, A., Stubbs, B., Stroobants, M., & De Herdt, A. (2014) · Disability and Rehabilitation · doi:10.3109/09638288.2013.874505 · Cited by 80
SCID-PANSS: Two tier diagnostic system for psychotic disorders
Kay, S. R., Opler, L. A., Spitzer, R. L., Williams, J. B. W., Fiszbein, A., & Gorelick, A. (1991) · Comprehensive Psychiatry · doi:10.1016/0010-440x(91)90085-q · Cited by 81
Cerebral blood flow identifies responders to transcranial magnetic stimulation in auditory verbal hallucinations
Homan, P., Kindler, J., Hauf, M., Hubl, D., & Dierks, T. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.114 · Cited by 80
Objectively measured motor activity in schizophrenia challenges the validity of expert ratings
Walther, S., Koschorke, P., Horn, H., & Strik, W. K. (2009) · Psychiatry Research · doi:10.1016/j.psychres.2008.06.020 · Cited by 81
Physical and mental health-related quality of life among older people with schizophrenia
Folsom, D. P., Depp, C. A., Palmer, B. W., Mausbach, B. T., Golshan, S., Fellows, I. E., Cárdenas, V., Patterson, T. L., KRAEMER, H. C., & Jeste, D. V. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2008.12.008 · Cited by 83
A prospective study of Quality of life in schizophrenia in three European countries
Heider, D., Angermeyer, M. C., Winkler, I., Schomerus, G., Bebbington, P., Brugha, T. S., Azorin, J., & Toumi, M. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.03.005 · Cited by 79
Observation of metabolic changes in chronic schizophrenia after neuroleptic treatment by in vivo hydrogen magnetic resonance spectroscopy.
Choe, B., Suh, T., Shinn, K., Lee, C.-W., Lee, C., & Paik, I. (1996) · Investigative Radiology · doi:10.1097/00004424-199606000-00006 · Cited by 83
Oral antipsychotics for the treatment of schizophrenia: heterogeneity in efficacy and tolerability should drive decision-making
Volavka, J., & Citrome, L. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560903061309 · Cited by 78
The Beck Cognitive Insight Scale in Outpatients with Psychotic Disorders: Further Evidence from a French-Speaking Sample
Favrod, J., Zimmermann, G., Raffard, S., Pomini, V., & Khazaal, Y. (2008) · The Canadian Journal of Psychiatry · doi:10.1177/070674370805301111 · Cited by 77
Hope, quality of life, and symptom severity in individuals with schizophrenia.
Landeen, J., Pawlick, J., Woodside, H., Kirkpatrick, H., & Byrne, C. (2000) · Psychiatric Rehabilitation Journal · doi:10.1037/h0095142 · Cited by 77
Applying linear mixed models to estimate reliability in clinical trial data with repeated measurements
Vangeneugden, T., Laenen, A., Geys, H., Renard, D., & Molenberghs, G. (2004) · Controlled Clinical Trials · doi:10.1016/j.cct.2003.08.009 · Cited by 75
Prediction of Working Memory Performance in Schizophrenia by Plasma Ratio of Clozapine toN-Desmethylclozapine
Rajji, T. K., Mulsant, B. H., Davies, S., Kalache, S. M., Tsoutsoulas, C., Pollock, B. G., & Remington, G. J. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.14050673 · Cited by 75
Metacognitions in patients with hallucinations and obsessive-compulsive disorder: The superstition factor
García‐Montes, J. M., Álvarez, M. P., Balbuena, C. S., Garcelán, S. P., & Cangas, A. J. (2005) · Behaviour Research and Therapy · doi:10.1016/j.brat.2005.07.008 · Cited by 74
Measuring quality of life in schizophrenia
McKenna, S. P. (1997) · European Psychiatry · doi:10.1016/s0924-9338(97)89096-7 · Cited by 72
Case Study: Risperidone in Children and Adolescents with Schizophrenia
Quintana, H., & Keshavan, M. S. (1995) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199510000-00014 · Cited by 74
Antipsychotic treatment may alter T-helper (TH) 2 arm cytokines
Pae, C., Yoon, C., Kim, T., Kim, J.-J., Park, S., Lee, C., Lee, S.-J., Lee, C., & Paik, I. (2005) · International Immunopharmacology · doi:10.1016/j.intimp.2005.10.004 · Cited by 73
Cognitive therapy for people with a schizophrenia spectrum diagnosis not taking antipsychotic medication: an exploratory trial
Morrison, A. P., Hutton, P., Wardle, M., Spencer, H. M., Barratt, S., Brabban, A., Callcott, P., Christodoulides, T., Dudley, R. E. J., French, P., et al. (2011) · Psychological Medicine · doi:10.1017/s0033291711001899 · Cited by 78
Are there gender differences in neuropsychological performance in patients with first-episode schizophrenia?
Albus, M., Hubmann, W., Mohr, F., Scherer, J., Sobizack, N., Franz, U., Hecht, S., Borrmann, M., & Wahlheim, C. (1997) · Schizophrenia Research · doi:10.1016/s0920-9964(97)00091-1 · Cited by 73
Benefits of Adjunct Modafinil in an Open-Label, Pilot Study in Patients With Schizophrenia
Rosenthal, M., & Bryant, S. (2003) · Clinical neuropharmacology · doi:10.1097/00002826-200401000-00011 · Cited by 86
The needs of carers: a comparison between eating disorders and schizophrenia
Graap, H., Bleich, S., Herbst, F., Scherzinger, C., Trostmann, Y., Wancata, J., & de Zwaan, M. (2008) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-008-0364-7 · Cited by 78
The effect of mind-body and aerobic exercise on negative symptoms in schizophrenia: A meta-analysis
Vogel, J. S., van der Gaag, M., Slofstra, C., Knegtering, H., Bruins, J., & Castelein, S. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.03.012 · Cited by 73
Effects of group musical therapy on inpatients with chronic psychoses: A controlled study
Hayashi, N., Tanabe, Y., Nakagawa, S., Noguchi, M., 岩田, 千., Koubuchi, Y., Watanabe, M., Okui, M., Takagi, K., Sugita, K., et al. (2002) · Psychiatry and Clinical Neurosciences · doi:10.1046/j.1440-1819.2002.00953.x · Cited by 69
Voxel-based gray and white matter morphometry correlates of hallucinations in schizophrenia: The superior temporal gyrus does not stand alone
van Tol, M., van der Meer, L., Bruggeman, R., Modinos, G., Knegtering, H., & Aleman, A. (2014) · NeuroImage Clinical · doi:10.1016/j.nicl.2013.12.008 · Cited by 71
The Swedish version of the Positive and Negative Syndrome Scale (PANSS) for schizophrenia
von Knorring, L., & Lindström, E. (1992) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1992.tb03298.x · Cited by 69
A latent structure analysis of the positive and negative symptoms in schizophrenia
Brekke, J. S., DeBonis, J. A., & Graham, J. W. (1994) · Comprehensive Psychiatry · doi:10.1016/0010-440x(94)90016-7 · Cited by 68
Telemonitoring of Medication Adherence in Patients with Schizophrenia
Frangou, S., Sachpazidis, I., Stassinakis, A., & Sakas, G. (2005) · Telemedicine Journal and e-Health · doi:10.1089/tmj.2005.11.675 · Cited by 68
The MCPP challenge test in schizophrenia: Hormonal and behavioral responses
Iqbal, N., Asnis, G. M., Wetzler, S. E., Kahn, R. S., Kay, S. R., & van Praag, H. M. (1991) · Biological Psychiatry · doi:10.1016/0006-3223(91)90233-c · Cited by 68
The role of experiential avoidance in paranoid delusions: an experience sampling study.
Udachina, A., Varese, F., Myin‐Germeys, I., & Bentall, R. P. (2014) · British Journal of Clinical Psychology · doi:10.1111/bjc.12054 · Cited by 66
Effect of cannabis use on the course of schizophrenia in male patients: A prospective cohort study
van Dijk, D., Koeter, M. W. J., Hijman, R., Kahn, R. S., & van den Brink, W. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.01.016 · Cited by 67
Interrater reliability of the Japanese version of the Positive and Negative Syndrome Scale and the appraisal of its training effect
Igarashi, Y., Hayashi, N., Yamashina, M., OTSUKA, N., Kuroki, N., Anzai, N., & Kazamatsuri, H. (1998) · Psychiatry and Clinical Neurosciences · doi:10.1046/j.1440-1819.1998.00425.x · Cited by 67
Significance of the Positive-negative Distinction in Schizophrenia
Kay, S. R. (1990) · Schizophrenia Bulletin · doi:10.1093/schbul/16.4.635 · Cited by 67
The relationship between dissociation and auditory verbal hallucinations in the flow of daily life of patients with psychosis
Varese, F., Udachina, A., Myin‐Germeys, I., Oorschot, M., & Bentall, R. P. (2011) · Psychosis · doi:10.1080/17522439.2010.548564 · Cited by 79
Validity and reliability of the Polish version of the Positive and Negative Syndrome Scale (PANSS)
Rzewuska, M. (2002) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.120 · Cited by 66
Ziprasidone vs clozapine in schizophrenia patients refractory to multiple antipsychotic treatments: The MOZART study
Sacchetti, E., Galluzzo, A., Valsecchi, P., Romeo, F., Gorini, B., & Warrington, L. E. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.02.017 · Cited by 66
A 12-month prospective follow-up study of patients with schizophrenia-spectrum disorders and substance abuse: changes in psychiatric symptoms and substance use.
Margolese, H., Negrete, J. C., Tempier, R., & Gill, K. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2005.11.019 · Cited by 76
The Impact of Aging, Cognition, and Symptoms on Functional Competence in Individuals With Schizophrenia Across the Lifespan
Kalache, S. M., Mulsant, B. H., Davies, S., Liu, A. Y., Voineskos, A. N., Butters, M. A., Miranda, D., Menon, M., Kern, R. S., & Rajji, T. K. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu114 · Cited by 67
Amisulpride augmentation therapy improves cognitive performance and psychopathology in clozapine-resistant treatment-refractory schizophrenia: a 12-week randomized, double-blind, placebo-controlled trial
Zhu, M., Liu, Z.-J., Hu, Q.-Y., Yang, J., Jin, Y., Zhu, N., Huang, Y., Shi, D.-H., Liu, M.-J., Tan, H.-Y., et al. (2022) · Military Medical Research · doi:10.1186/s40779-022-00420-0 · Cited by 65
Interrater reliability of the Structured Clinical Interview for the Positive and Negative Syndrome Scale for schizophrenia
Lindström, E., Wieselgren, I., & von Knorring, L. (1994) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1994.tb08091.x · Cited by 65
Negative Symptoms in Schizophrenia: Neurobiological Models and Treatment Response
GOFF, D. C., & Evins, A. E. (1998) · Harvard Review of Psychiatry · doi:10.3109/10673229809000313 · Cited by 65
Relationship Between Self-Focused Attention and Dissociation in Patients With and Without Auditory Hallucinations
Perona-Garcelán, S., Cuevas-Yust, C., García-Montes, J. M., Pérez-Álvarez, M., Ductor-Recuerda, M. J., Salas-Azcona, R., Gómez-Gómez, M. T., & Rodríguez-Martín, B. (2008) · Journal of Nervous and Mental Disease · doi:10.1097/nmd.0b013e318165c7c1 · Cited by 75
Principal components and further possibilities with the PANSS
von Knorring, L., & Lindström, E. (1995) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1995.tb05937.x · Cited by 64
Sexual functioning, psychopathology and quality of life in patients with schizophrenia
Fan, X., Henderson, D. C., Chiang, E., Briggs, L. B. N., Freudenreich, O., Evins, A. E., Cather, C., & GOFF, D. C. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.04.033 · Cited by 67
A Group Intervention to Promote Healthy Self-Concepts and Guide Recovery in First Episode Schizophrenia: A Pilot Study.
McCay, E. A., Beanlands, H. J., Leszcz, M., Goering, P. N., Seeman, M. V., Ryan, K., Johnston, N., & Vishnevsky, T. (2006) · Psychiatric Rehabilitation Journal · doi:10.2975/30.2006.105.111 · Cited by 63
Efficacy of low-dose mirtazapine in neuroleptic-induced akathisia: a double-blind randomized placebo-controlled pilot study
Poyurovsky, M., Epshtein, S., Fuchs, C., Schneidman, M., Weizman, R., & Weizman, A. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000084027.22282.16 · Cited by 62
A double‐blind, placebo‐controlled trial of sibutramine for clozapine‐associated weight gain
Henderson, D. C., Fan, X., Copeland, P. M., Borba, C. P. C., Daley, T. B., Nguyen, D. D., Zhang, H., Hayden, D. L., Freudenreich, O., Cather, C., et al. (2006) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2006.00855.x · Cited by 62
Insomnia and suicidal ideation in nonaffective psychosis
Miller, B. J., Parker, C. B., Rapaport, M. H., Buckley, P. F., & McCall, W. V. (2018) · SLEEP · doi:10.1093/sleep/zsy215 · Cited by 62
Improving insight into delusions: a pilot study of metacognitive training for patients with schizophrenia
Favrod, J., Maire, A., Bardy, S., Pernier, S., & Bonsack, C. (2010) · Journal of Advanced Nursing · doi:10.1111/j.1365-2648.2010.05470.x · Cited by 61
Delivering cognitive therapy to people with psychosis in a community mental health setting: an effectiveness study
Morrison, A. P., Renton, J. C., Williams, S. R., Dunn, H., Knight, A., Kreutz, M., Nothard, S., Patel, U. J., & Dunn, G. (2004) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2004.00299.x · Cited by 61
Efficacy of the Community Re-Entry Module for patients with schizophrenia in Beijing, China: outcome at 2-year follow-up
Xiang, Y., Weng, Y., Li, W.-Y., Gao, L., Chen, G.-L., Xie, L., Chang, Y.-L., Tang, W. K., & Ungvari, G. S. (2006) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.106.023697 · Cited by 61
Auditory event-related potentials and clinical scores in unmedicated schizophrenic patients
Laurent, A., Garcı́a-Larrea, L., d’Amato, T., Bosson, J., Saoud, M., Marie-Cardine, M., Mauguı̀ere, F., & Jean Dalery, A. (1999) · Psychiatry Research · doi:10.1016/s0165-1781(99)00038-4 · Cited by 61
Positive and negative symptoms/syndromes in schizophrenia: reliability and validity of different diagnostic systems
Peralta, V., Cuesta, M. J., & de León, J. (1995) · Psychological Medicine · doi:10.1017/s0033291700028075 · Cited by 61
A randomized, double blind, sham-controlled trial of repetitive transcranial magnetic stimulation (rTMS) in the treatment of negative symptoms in schizophrenia
Kumar, N. K., Vishnubhatla, S., Nehra, A., Minhas, S., & Gupta, P. (2020) · Brain stimulation · doi:10.1016/j.brs.2020.02.016 · Cited by 60
Illness-related components for the family burden of relatives to patients with psychotic illness
Hjärthag, F., Helldin, L., Karilampi, U., & Norlander, T. (2009) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-009-0065-x · Cited by 59
Quality of life and temperament factors in schizophrenia: Comparative study of patients, their siblings and controls
Kurs, R., Farkash, H., & Ritsner, M. S. (2005) · Quality of Life Research · doi:10.1007/s11136-004-0799-6 · Cited by 58
Psychosocial and neuropsychiatric predictors of subjective recovery from psychosis
Morrison, A. P., Shryane, N. M., Beck, R., Heffernan, S., Law, H., McCusker, M., & Bentall, R. P. (2013) · Psychiatry Research · doi:10.1016/j.psychres.2013.05.008 · Cited by 63
Negative Symptoms, Trauma, and Autobiographical Memory
Harrison, C. L., & Fowler, D. G. (2004) · The Journal of Nervous and Mental Disease · doi:10.1097/01.nmd.0000144693.12282.11 · Cited by 58
Antipsychotic Drug Treatment in the Prodromal Phase of Schizophrenia
Cannon, T. D., HUTTUNEN, M. O., Dahlström, M., Larmo, I., Räsänen, P. K., & Jüriloo, A. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.7.1230 · Cited by 58
Evaluating depressive symptoms and their impact on outcome in schizophrenia applying the Calgary Depression Scale
Schennach-Wolff, R., Obermeier, M., Seemüller, F., Jäger, M., Messer, T., Laux, G., Pfeiffer, H., Naber, D., Schmidt, L., Gäebel, W., et al. (2010) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2010.01608.x · Cited by 57
Improvement of inter‐rater reliability of PANSS items and subscales by a standardized rater training
Müller, M. J., & Wetzel, H. (1998) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1998.tb10055.x · Cited by 57
Changes in oxidative stress markers in patients with schizophrenia: The effect of antipsychotic drugs
Tsai, M.-C., Liou, C., Lin, T., Lin, I., & Huang, T. (2013) · Psychiatry Research · doi:10.1016/j.psychres.2013.01.023 · Cited by 57
Basic Emotion Recognition and Psychopathology in Schizophrenia
Larøi, F., Fonteneau, B., Mourad, H., & Raballo, A. (2010) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0b013e3181c84cb0 · Cited by 57
Cognitive Behavioural Therapy for Auditory Hallucinations: Effectiveness and Predictors of Outcome in a Specialist Clinic
Thomas, N., Rossell, S. L., Farhall, J., Shawyer, F., & Castle, D. J. (2010) · Behavioural and Cognitive Psychotherapy · doi:10.1017/s1352465810000548 · Cited by 57
A randomised controlled trial of a group intervention to reduce engulfment and self-stigmatisation in first episode schizophrenia
McCay, E. A., Beanlands, H. J., Zipursky, R. B., Roy, P., Leszcz, M., Landeen, J., Ryan, K., Conrad, G., Romano, D., Francis, D., et al. (2007) · Advances in Mental Health · doi:10.5172/jamh.6.3.212 · Cited by 57
Addition of memantine to antipsychotic treatment in schizophrenia inpatients with residual symptoms: A preliminary study
Krivoy, A., Weizman, A., Tatsa-Laur, L., Hellinger, N., Zemishlany, Z., & Fischel, T. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.07.008 · Cited by 57
Longitudinal predictors of subjective recovery in psychosis
Law, H., Shryane, N., Bentall, R. P., & Morrison, A. P. (2016) · British Journal of Psychiatry · doi:10.1192/bjp.bp.114.158428 · Cited by 55
Subjective versus objective cognition: Evidence for poor metacognitive monitoring in schizophrenia
Moritz, S., Balzan, R. P., Bohn, F., Veckenstedt, R., Kolbeck, K., Bierbrodt, J., & Dietrichkeit, M. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.08.021 · Cited by 55
“With a little help from my friends” social predictors of clinical recovery in first-episode psychosis
Bjørnestad, J. R., Hegelstad, W. T. V., Joa, I., Davidson, L., Larsen, T. K., Melle, I. S., Veseth, M., Johannessen, J. O., & Brønnick, K. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.05.041 · Cited by 59

Authors: Kay, S. R., Opler, L. A., & Lindenmayer, J.-P.
Affiliations: Albert Einstein College of Medicine (US)
ORCID: Opler, Lewis A.
Lindenmayer, Jean-Pierre
Venue: Psychiatry Research
Publisher: Elsevier BV
Published: 1988-01
Volume: 23
Issue: 1
Pages: 99-110
ISSN: 0165-1781 (ISSN-L)
DOI: 10.1016/0165-1781(88)90038-8
OpenAlex: W2100828552
Cited by: 1,007
References: 28
Citations by year: 2026: 16 · 2025: 30 · 2024: 38 · 2023: 28 · 2022: 33 · 2021: 43 · 2020: 33 · 2019: 37 · 2018: 41 · 2017: 33 · 2016: 45 · 2015: 49 · 2014: 37 · 2013: 40 · 2012: 44
FWCI: 8.23
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Psychiatry Research (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Social Sciences › Decision Sciences › Management Science and Operations Research › Psychometric Methodologies and Testing
Social Sciences › Psychology › Applied Psychology › Psychological Testing and Assessment
Keywords: PANSS, schizophrenia, psychometric properties, inter-rater reliability, criterion validity, construct validity, positive symptoms, negative symptoms, cross-validation
MeSH terms: Adult, Female, Humans, Male, Prognosis, Psychiatric Status Rating Scales, Psychometrics, Schizophrenia, Schizophrenic Psychology

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Reliability and validity of the positive and negative syndrome scale for schizophrenics

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks